MENU

This tech stock just hit a 52-week low. Is it a bargain buy?

The share price of software provider Integrated Research Limited (ASX: IRI) has fallen another 4% to a 52-week low of $1.90 in Monday trade. The share price has now fallen 22% since last Tuesday’s announcement which revealed that the company’s CEO John Merakovsky had handed in his resignation for personal reasons. It later emerged that Mr. Merakovsky will join the Wesfarmers Ltd (ASX: WES) subsidiary Flybuys as its new CEO.

Integrated Research is normally a thinly traded small cap, but volumes have jumped over the last several trading days following the CEO’s resignation. The resignation follows last month’s announcement of Steve Killelea’s retirement from the Board as both the Chairman and a Non-Executive Director.

Steve Killelea is the founder of Integrated Research and the company’s largest shareholder with a 39.5% stake in the business. He has subsequently entered into a consulting contract with Integrated Research for 2 years to provide assistance and act in an advisory capacity to the Strategic Committee. Furthermore, he has also indicated that he has no immediate plans to reduce his ownership stake.

Is it time to buy? 

Integrated Research has provided performance monitoring, diagnostics and management software solutions for business-critical computing environments via its Prognosis products for 30 years. The company boasts an impressive amount of blue chip clients with over 125 of the Fortune 500 using its products. New customers such as BHP Billiton Limited (ASX: BHP) and Coles Group Limited (ASX: COL) were also added in FY18 among others.

By the company’s high standards, FY18 was a subdued year with revenue flat at $91.2 million and net profit after tax increasing by only 4% to $19.2 million. Revenue was flat due to a cyclical downturn in the company’s Infrastructure line and underperformance in its Payments line. The weakness in these 2 business lines was offset by growth from the Unified Communications and Consulting Services lines.

At current prices, shares of Integrated Research are trading for around 16 times the FY19 consensus estimate of 11.95 cents. Hitting this number would represent earnings growth of around 7% over a soft FY18. This is the cheapest valuation the company has traded for in quite some time and the last time the share price traded at these kinds of levels was in April 2016.

An underwhelming FY18 relative to its growth in prior years and the departure of key personnel warrants some caution for investors even at these kinds of prices. Therefore, it might be prudent to wait until the company reports its interim results in February before opening a position. In the meantime, investors can consider these dividend picks for 2019.

NEW! Top 3 Dividend Bets for 2019

With interest rates likely to stay at rock bottom for months (or YEARS) to come, income-minded investors have nowhere to turn... except dividend shares. That’s why The Motley Fool’s top analysts have just prepared a brand-new report, laying out their top 3 dividend bets for 2019.

Hint: These are 3 shares you’ve probably never come across before.

They’re not the banks. Not Woolies or Wesfarmers or any of the “usual suspects.”

We think these 3 shares offer solid growth prospects over the next 12 months. The first two currently offer fat, fully franked yields. The last is a surprising REIT offering you the benefits of being a landlord with none of the hassle! You’ll discover all three names and codes in "The Motley Fool’s Top 3 Dividend Shares for 2019."

Even better, your copy is free when you click the link below. Fair warning: This report is brand new and may not be available forever. Click the link below to be among the first investors to get access to this timely, important new research!

The names of these top 3 dividend bets are all included. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free copy right now!

Motley Fool contributor Tim Katavic has no financial interest in any company mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool Australia has recommended Integrated Research Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.